Luke Spray results 1
· Newest (Page 1/1, per page 25)
Author: Luke Spray ×Clear All Filters
Search Results
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarctionNARA Subscribed
Myocardial infarction (MI) accelerates immune ageing characterised by lymphopenia, expansion of terminally differentiated CD8 + T-lymphocytes (CD8 + T EMRA ) and inflammation. Pre-clinical data showed that TA-65, an oral telomerase activator, reduced immune ageing and inflammation after MI. We conducted a double blinded randomised controlled pilot trial evaluating the use of TA-65 to reduce immune cell ageing in patients follo...
Previous1Next